REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/30/2026
Back to search
Official data from USPTO
APTORUM THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
APTORUM THERAPEUTICS
ST13
US500000087668718Class
5, 10, 42, 44
Filing
87668718
Registration
6303551
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
67
Latest update
03/31/2026
Trademark type
Word
Nice classes
5, 10, 42, 44
Filing date
11/01/2017
Registration date
03/30/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/30/2021
Last transaction
03/31/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
Hong Kong, KY
Examiner
DICKEY, ERICA
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Aptorum Group Limited
Aptorum Group Limited
Representatives
Sam Yip Idea Intellectual Limited
Technical classification
Nice Classes
Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and traditional Chinese medicine for the diagnosisprevention and treatment of gastro-intestinal diseases and disorders; pharmaceutical preparations for the diagnosisprevention and treatment of diseases and disorders relating to women's healthgynecological diseases and disordersendometrial disease and disorders; pharmaceutical products and preparations and traditional Chinese medicine for the treatment of orthopedic injuries and conditions; pharmaceutical preparations and traditional Chinese medicine for the diagnosisprevention and treatment of ophthalmological diseasesconditions and disorders; pharmaceutical preparations and traditional Chinese medicine for the diagnosisprevention and treatment of neurological diseases and disorders; pharmaceutical preparations and traditional Chinese medicine for the diagnosisprevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations and traditional Chinese medicine for the diagnosisprevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations and traditional Chinese medicine for the diagnosisprevention and treatment of cognitive deficiencies and neurodegenerative diseases and for the treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilities
Class 10
Surgical apparatus and instruments for use in the field of gastro-intestinal medicineorthopedics and ophthalmology; Medical apparatus and instrumentssurgical robotic apparatus and non-invasive detection tools in the nature of medical imaging devices for detecting brain plaques; medical and surgical apparatusinstruments and parts therefor for use in magnetic resonance imaging and other imaging-guided surgeryincluding markers for use in patient registration in the nature of procedures used in computer assisted surgeries and tracking the location of instruments within the patient's body during image guided surgeries; medical and surgical apparatusinstruments and parts therefor for use in minimum invasive surgery; medical apparatus for the treatment of neurodegenerative diseases; medical instruments and articlesanalytical apparatus for diagnosis of neurodegenerative diseases; analysis apparatus for medical purposesnon-invasive detection apparatus probes and imaging devices for use in the fields of neurology and neurobiology; diagnostic apparatus for medical purposesfor diagnosing plagues and images in brain for use in the fields of neurology and neurobiology; medical diagnostic apparatus for the detection of neurodegenerative diseases and conditions; surgicalmedical apparatus and instruments for the preventiontreatment and repair of neurodegenerative diseases and disorders; medical testing apparatus used for the treatment of cognitive deficienciesneurodegenerative diseases and for the treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilities
Class 42
Pre-clinical and clinical services for pharmaceutical and diagnostic test formulation researchpharmacological studiestoxicokinetic and pharmacokinetic studiestoxicity testsbioequivalence studiesstability testsclinical trialsclinical researchmedical research in the fields of gastro-intestinal medicinewomen's healthorthopedics and ophthalmology; conducting clinical trials for diagnostic tests and for pharmaceutical preparations in the fields of gastro-intestinal medicinewomen's healthorthopedics and ophthalmology; scientific and toxicology research services in the fields of gastro-intestinal medicinewomen's healthorthopedics and ophthalmology; biopharmaceutical research for development of targeted therapies for use in the treatment of gastrointestinal diseases and disordersdiseases and disorders relating to woman's healthorthopedics and orthopedic injuries and conditionsophthalmological diseasesconditions and disorders; providing medical testing services for research purposes and medical and scientific research information in the fields of gastro-intestinal medicinewomen's healthorthopedics and ophthalmology; pre- clinical and clinical services for formulation researchpharmacological studiestoxicokinetic and pharmacokinetic studiestoxicity testsbioequivalence studiesstability testsclinical trialsclinical researchmedical research in the field of neurodegenerative diseases; conducting clinical trials for diagnostic tests and for pharmaceutical preparations in the field of neurodegenerative diseases; scientific and toxicology research services in the field of neuroscience and neurodegenerative diseases; biopharmaceutical research for development of targeted therapies for use in the treatment of neurodegenerative diseases and disorders; providing medical testing services for research purposes and medical and scientific research information in the fields of degenerative and neurodegenerative diseases; consulting for pharmacology and medical toxicology in the fields of gastro-intestinal medicinewomen's healthorthopedics and ophthalmology; consulting for pharmacology and toxicology in the field of neurodegenerative diseases and disorders
Class 44
Providing targetedindividualized treatment regimenstherapies or combination therapy for patients suffering from gastro-intestinal diseases and disordersdiseases and disorders relating to woman's healthorthopedics and orthopedic injuries and conditionsophthalmological diseasesconditions and disorders; medical testing for diagnostic or treatment purposes in the fields of gastro-intestinal medicinewomen's healthorthopedics and ophthalmology; providing targetedindividualized treatment regimenstherapies or combination therapy for patients suffering from neurodegenerative diseases and disorders; medical testing for diagnostic or treatment purposes in the field of neurodegenerative diseases and disorders
Publications
History of USPTO decisions and trademark events.
67 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/30/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/12/2021
PUBO
PUBLISHED FOR OPPOSITION
01/12/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/23/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/09/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/30/2020
OTHE
CASE RETURNED TO EXAMINATION
11/30/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
11/30/2020
EX1G
SOU EXTENSION 1 GRANTED
11/30/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/06/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/06/2020
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
10/06/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/06/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/06/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/06/2020
EXT1
SOU EXTENSION 1 FILED
06/10/2020
EEXT
SOU TEAS EXTENSION RECEIVED
06/10/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/09/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/07/2020
GNRT
NON-FINAL ACTION E-MAILED
05/07/2020
CNRT
NON-FINAL ACTION WRITTEN
05/07/2020
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
04/28/2020
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
04/10/2020
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
04/10/2020
APET
ASSIGNED TO PETITION STAFF
04/10/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/10/2020
44EP
44(e) PETITION - RECEIVED
02/06/2020
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
02/06/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/10/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/15/2019
PUBO
PUBLISHED FOR OPPOSITION
10/15/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/25/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/06/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
09/06/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/06/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
09/06/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/06/2019
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
08/26/2019
GPRA
PRIORITY ACTION E-MAILED
08/26/2019
CPRA
PRIORITY ACTION WRITTEN
08/26/2019
NREV
NOTICE OF REVIVAL - E-MAILED
08/02/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/02/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/02/2019
ALIE
ASSIGNED TO LIE
08/02/2019
PGRR
PETITION GRANTED - RESPONSE RECEIVED
08/02/2019
APET
ASSIGNED TO PETITION STAFF
07/30/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/08/2019
PROA
TEAS PETITION TO REVIVE RECEIVED
06/08/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/07/2018
GNRT
NON-FINAL ACTION E-MAILED
12/07/2018
CNRT
NON-FINAL ACTION WRITTEN
12/07/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/13/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/12/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/12/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/05/2018
GNFR
FINAL REFUSAL E-MAILED
09/05/2018
CNFR
FINAL REFUSAL WRITTEN
09/05/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/15/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/14/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/14/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/14/2018
GNRT
NON-FINAL ACTION E-MAILED
02/14/2018
CNRT
NON-FINAL ACTION WRITTEN
02/14/2018
DOCK
ASSIGNED TO EXAMINER
02/12/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/11/2017
NWAP
NEW APPLICATION ENTERED
11/04/2017
Continuous trademark protection
Get notified about every new filing that threatens APTORUM THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.